The Reagan-Udall Foundation for the FDA, in collaboration with the U.S. Food and Drug Administration, is conducting a project to identify areas of opportunity to strengthen the quality and transparency of real-world data related to medical devices. Through a series of discussions with experts from across the health data ecosystem, the Foundation is gathering perspectives on the challenges that affect device data as they are collected, exchanged, curated, and prepared for use in evidence. The goal is to build shared understanding of where gaps exist along the data pipeline from initial collection through all extractions, loadings, and transformations. Insights from this work will be summarized publicly to inform priority actions and future collaboration to help support relevant and reliable real-world evidence.